Angioimmunoblastic T-cell lymphoma surgery: Difference between revisions
Created page with "__NOTOC__ {{Angioimmunoblastic T-cell lymphoma}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing..." |
No edit summary |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Angioimmunoblastic T-cell lymphoma}} | {{Angioimmunoblastic T-cell lymphoma}} | ||
{{CMG}}, {{AE}}{{Sab}} | |||
==Overview== | |||
Surgical intervention is not recommended for the management of angioimmunoblastic T-cell lymphoma. | |||
==Surgery== | |||
Surgical intervention is not recommended for the management of angioimmunoblastic T-cell lymphoma. | |||
==References== | ==References== | ||
Line 9: | Line 12: | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
Line 16: | Line 18: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] |
Latest revision as of 21:45, 15 April 2019
Angioimmunoblastic T-cell lymphoma Microchapters |
Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Angioimmunoblastic T-cell lymphoma surgery On the Web |
American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma surgery |
Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma |
Risk calculators and risk factors for Angioimmunoblastic T-cell lymphoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]
Overview
Surgical intervention is not recommended for the management of angioimmunoblastic T-cell lymphoma.
Surgery
Surgical intervention is not recommended for the management of angioimmunoblastic T-cell lymphoma.
References